AB1731-PARE INFLUENCE OF A MULTICOMPONENT EDUCATIONAL PROGRAM ON PATIENT REPORTED OUTCOMES MEASUREMENTS IN A GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS
Authors: N. Pinto-Florez, Z. Castaño, F. Rodriguez, G. S. Rodríguez-Vargas, J. A. Rubio-Rubio, A. Rojas-Villarraga, P. Santos-Moreno
Journal: Annals of the Rheumatic Diseases (2023)

<h3>Background</h3> Educational strategies in patients with rheumatoid arthritis (RA) are a fundamental tool for the objective measurement of clinimetry by patients (Patient Reported Outcomes Measurements- PROMs). <h3>Objectives</h3> The objective of this study is to evaluate whether there are differences in the measurement of clinimetry when performed by a medical group (MG) with PROMs in an educational context. <h3>Methods</h3> Cross-sectional study. A group of adult patients with RA who participated in a multicomponent RA education program (EMRA) and another who did not participate in this program (NEMRA) were included. The multicomponent educational program is responsible for educating the patient for self-management and management of their health condition, providing different knowledge regarding the disease, including clinimetry, with a duration of 14 months (divided into three levels, mixed face-to-face and virtual). The group of EMRA and NEMRA patients performed the PROMs, through a form designed in "Google forms". Clinimetry measurements were performed by a medical group, MG (blind to the type of patient group) with a difference of 1 week. Clinical, sociodemographic, and clinimetry variables were included in the RedCap platform. The MDHAQ, RAPID3, PAS, EQ5 and Fatigue scales were evaluated by the MG and the two groups of patients. Univariate and bivariate analysis was performed. A comparison of the medians of the variables evaluated by PROMs and by the MG (Wilcoxon for paired data) was made. The ethics committee approved the study design. <h3>Results</h3> 91 women were included. The median duration of the disease was 10.9 years (12.1). 30.8% had polyautoimmunity. The EMRA group had a higher proportion of education above secondary school (p=0.013). In the EMRA group, there were no significant differences between the clinimetry evaluated by the MG and the PROMs. In the NEMRA group, significant differences were found in 4 of the 6 variables evaluated (Table 1). <h3>Conclusion</h3> PROMs measurements have a value comparable to the clinimetry performed by the MG in those patients who are under an educational program with emphasis on self-management of their disease. This can be valuable to have an objective measurement by the patient with RA that can be useful at the time of the consultation, save time in its development and facilitate the adoption of therapeutic behaviors. It is suggested that for a good development of PROMs, patients have prior educational training so that these measurements are similar to those performed by the MG. <h3>REFERENCES:</h3> NIL. <h3>Acknowledgements:</h3> NIL. <h3>Disclosure of Interests</h3> NORALMA PINTO-FLOREZ: None declared, Zohelia Castaño: None declared, Fernando Rodriguez: None declared, Gabriel-Santiago Rodríguez-Vargas: None declared, Jaime-Andrés Rubio-Rubio: None declared, Adriana Rojas-Villarraga: None declared, Pedro Santos-Moreno Speakers bureau: Abbvie, Abbott, Biopas-UCB, Bristol, Janssen, Pfizer, Roche, Sanofi, Grant/research support from: Abbvie, Abbott, Biopas-UCB, Bristol, Janssen, Pfizer, Roche, Sanofi.